Evidence map›Paper›PMID 25174864›Full record

ArticleThe Journal of allergy and clinical immunology2014

Filaggrin loss-of-function mutations are associated with food allergy in childhood and adolescence.

Devasmitha Venkataraman, Nelís Soto-Ramírez, Ramesh J Kurukulaaratchy, John W Holloway, Wilfried Karmaus, Susan L Ewart, S Hasan Arshad, Mich Erlewyn-Lajeunesse

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 3 pooled it
19.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 3 syntheses or guidelines pooled it, 196 citations in OpenAlex.

  1. Pooled it
  2. Skin barrier-related genes in childhood atopic dermatitis, asthma, and allergy: A systematic review and meta-analysis.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Pooled it
  3. Pooled it
  4. Identification of two early life eczema and non-eczema phenotypes with high risk for asthma development.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2019
    Trial
  5. Article
  6. The Food Allergy-Eosinophilic Esophagitis Continuum: Implications for Food Allergy Immunotherapy.The journal of allergy and clinical immunology. In practice · 2026
    Review
  7. The Role of the Indoor Exposome in Food Allergy Development.Current allergy and asthma reports · 2026
    Review
  8. Review
  9. Review
  10. Article
  11. The age of eczema onset and multiple food allergies.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2026
    Article
  12. Dietary Antigen Interaction with Intestinal Epithelial Cells.Current allergy and asthma reports · 2026
    Review
  13. Review
  14. Review
  15. Detection of Anaphylaxis Through the Cutaneous Barrier.Current allergy and asthma reports · 2025
    Review
  16. Early-Life Allergen Exposure and Its Influence on Risk of Atopic Disease.The journal of allergy and clinical immunology. In practice · 2025
    Review
  17. Review
  18. Article
  19. Article
  20. A mutation inbioRxiv : the preprint server for biology · 2023
    Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Devasmitha VenkataramanUniversity of Southampton, Faculty of Medicine, Southampton, United Kingdom; James Cook University Hospital, Middlesbrough, United Kingdom.
Nelís Soto-RamírezDivision of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tenn.
Ramesh J KurukulaaratchyDavid Hide Asthma and Allergy Research Centre, Isle of Wight, United Kingdom; University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.
John W HollowayClinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Wilfried KarmausDivision of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tenn.
Susan L EwartCollege of Veterinary Medicine, Michigan State University, East Lansing, Mich.
S Hasan ArshadDavid Hide Asthma and Allergy Research Centre, Isle of Wight, United Kingdom; University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom; Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom. Electronic address: S.H.Arshad@soton.ac.uk.
Mich Erlewyn-LajeunesseUniversity Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom; Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.
University Hospital Southampton NHS Foundation Trust · GBUniversity of Memphis · USDavid Hide Asthma and Allergy Research Centre · GBJames Cook University Hospital · GBMichigan State University · USUniversity of Southampton · GB

Funding

Transgenerational epigenetic inheritance of allergy in a multigenerational cohortR01AI091905 · NIAID · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI KARMAUS, WILFRIED JJ · 2011 to 2015
$2.7M
Genetic &epidemiologic cohort study of asthma &allergyR01AI061471 · NIAID · MICHIGAN STATE UNIVERSITY · PI EWART, SUSAN L · 2005 to 2009
$1.8M
Epidemiology of asthma: risk and prognosis in a cohort from birth to adolescenceR01HL082925 · NHLBI · ST. MARY'S HOSPITAL NEWPORT · PI ARSHAD, SYED HASAN · 2007 to 2010
$1.7M
NHLBI NIH HHS R01 HL082925NHLBI NIH HHS R01-HL082925NIAID NIH HHS R01 AI061471NIAID NIH HHS R01-AI061471NIAID NIH HHS R01 AI091905NIAID NIH HHS R01-AI091905
6 · The paper itself

Abstract

backgroundFilaggrin is an epidermal protein that has a role in skin barrier function. Filaggrin loss-of-function (FLG-LOF) mutations are a significant risk factor for eczema and atopy, but their association with food allergy (FA) is less clear.

objectiveWe explored the longitudinal relationship between 3 common FLG-LOF mutations and FA using the Isle of Wight birth cohort.

methodsFA diagnosis was based on recognized allergic reactions within 4 hours after exposure to known food allergens. Food allergen sensitization (FAS) was identified by using skin prick tests conducted between 1 and 18 years of age to a range of food allergens. Three FLG mutations were genotyped in 1150 (79%) of 1456 children. The temporal relationships between FA, FAS, and eczema in children with FLG mutations were explored by using path analysis with total, direct, and indirect effect models.

resultsThere was a significant total effect of FLG-LOF mutations on the risk of FA in later childhood at the ages of 10 (odds ratio, 31.46; 95% CI, 2.86 to >100) and 18 (odds ratio, 4.25; 95% CI, 1.55-11.61) years. Path analysis showed that there was no direct effect of FLG-LOF mutations on FA at any age; however, an indirect effect was found on FA at all ages through eczema and FAS in the earlier years.

conclusionFLG-LOF mutations are associated with FA in older children through eczema and FAS during early childhood. Our results highlight a biologically plausible pathway, which suggests that skin barrier function is important in the development and persistence of FA.

Indexed as

AdolescentAllergensChildChild, PreschoolCohort StudiesFemaleFilaggrin ProteinsFollow-Up StudiesFood HypersensitivityGenotypeHumansInfantIntermediate Filament ProteinsMaleMutationSkinAllergensFilaggrin ProteinsFLG protein, humanIntermediate Filament ProteinseczemafilaggrinFLG-LOFfood allergen sensitizationFood allergypath analysisprediction

Identifiers

PMID25174864
PMCPMC4186905
OpenAlexW2138545858

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.